HAEMONETICS CORP MASS - NOTE 3/0

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Debt / NOTE 3/0
Market price (% of par)
90.15%
Total 13F principal
$324,676,273
Principal change
-$214,249,058
Total reported market value
$293,289,879
Number of holders
47
Value change
-$199,609,133
Number of buys
11
Number of sells
25

Institutional Holders of HAEMONETICS CORP MASS - NOTE 3/0 as of Q2 2024

As of 30 Jun 2024, HAEMONETICS CORP MASS - NOTE 3/0 was held by 47 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $324,676,273 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, FRANKLIN RESOURCES INC, TENOR CAPITAL MANAGEMENT Co., L.P., BANK OF MONTREAL /CAN/, MACKAY SHIELDS LLC, AVIVA PLC, OSTERWEIS CAPITAL MANAGEMENT INC, READYSTATE ASSET MANAGEMENT LP, WELLS FARGO & COMPANY/MN, and BRAIDWELL LP. This page lists 47 institutional bondholders reporting positions for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.